Prominent Lipid Parameters Correlated with Trunk-to-Leg and Appendicular Fat Ratios in Severe Pediatric Obesity

Authors: Mustafa M. Donma, Orkide Donma

Abstract:

Alterations in lipid parameters as well as in the fat distribution of the body are noteworthy during the evaluation of obesity stages. Total cholesterol (TC), triglycerides (TRG), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C) are basic lipid fractions. Fat deposited in trunk and extremities may give considerable amount of information. Ratios such as trunk-to-leg fat ratio (TLFR) and trunk-to-appendicular fat ratio (TAFR) are derived from distinct fat distribution in these areas. In this study, lipid fractions and TLFR as well as TAFR were evaluated and the distinctions among healthy, obese (OB) and morbid obese (MO) groups were investigated. Three groups [normal body mass index (N-BMI), OB, MO] were constituted. Ages and sexes of the groups were matched. The study protocol was approved by the Non-interventional Ethics Committee of Tekirdag Namik Kemal University. Written informed consent forms were obtained from the parents of the participants. Anthropometric measurements (height, weight, waist circumference, hip circumference, head circumference, neck circumference) were recorded during the physical examination. BMI values were calculated. Total, trunk, leg and arm fat mass values were obtained by TANITA Bioelectrical Impedance Analysis. These values were used to calculate TLFR and TAFR. Systolic (SBP) and diastolic blood pressures (DBP) were measured. Routine biochemical tests including lipid fractions were performed. Data were evaluated using SPSS software. p value smaller than 0.05 was accepted as significant. There was no difference among the age values and gender ratios of the groups. Any statistically significant difference was not observed in terms of DBP, TLFR as well as serum lipid fractions. Higher SBP values were measured both in OB and MO children than those with N-BMI. TAFR showed a significant difference between N-BMI and OB groups. Statistically significant increases were detected between insulin values of N-BMI group and OB as well as MO groups. There were bivariate correlations between LDL and TLFR as well as TAFR values in MO group. When adjusted for SBP and DBP, partial correlations were calculated for LDL-TLFR as well as LDL-TAFR. Much stronger partial correlations were obtained for the same couples upon controlling for TRG and HDL-C. Much stronger partial correlations observed in MO children emphasize the potential transition from morbid obesity to metabolic syndrome. These findings have concluded that LDL-C may be suggested as a discriminating parameter between OB and MO children.

Keywords: Children, lipid parameters, obesity, trunk-to-leg fat ratio, trunk-to-appendicular fat ratio.

References:

[1] C. E. Cioffi, J. A. Alvarez, J. A. Welsh, and M. B. Vos, “Truncal-to-leg fat ratio and cardiometabolic disease risk factors in US adolescents: NHANES 2003-2006,” Pediatr Obes., vol.14, no.7, pp.e12509, Jul. 2019.
[2] L. B. Sherar, J. C. Eisenmann, P. D. Chilibeck, N. Muhajarine, S. Martin, D. A. Bailey, and A. D. Baxter-Jones AD. “Relationship between trajectories of trunk fat mass development in adolescence and cardiometabolic risk in young adulthood,” Obesity (Silver Spring), vol.19, no.8, pp.1699-1706, Aug 2011.
[3] E.N. Barbour-Tuck, M. C. Erlandson, L. B. Sherar, J. C. Eisenmann, N. Muhajarine, H. Foulds, H. Vatanparast, C. Nisbet, S. Kontulainen, and A. D. G. Baxter-Jones, “Relationship between trajectories of trunk fat development in emerging adulthood and cardiometabolic risk at 36 years of age,” Obesity (Silver Spring), vol.27, no.10, pp.1652-1660, Oct. 2019.
[4] I. Kishimoto, “Trunk-to-leg fat ratio-an emerging early marker of childhood adiposity, and future cardiometabolic risks,” Circ. J., vol.80, no.8, pp.1707-1709, Jul. 2016.
[5] K. Kouda, N. Dongmei, J. Tamaki, M. Iki, T. Tachiki, E. Kajita, Y. Nakatani, K. Uenishi, S. Kagamimori, Y. Kagawa, and H. Yoneshima, “Relative importance of central and peripheral adiposities on cardiometabolic variables in females: A Japanese population-based study,” J. Clin. Densitom., vol.20, no.1, pp.58-65, Jan-Mar 2017.
[6] P. P. Zimmet, K. G. AlbertiG, F. Kaufman, N. Tajima, M. Silink, S. Arslanian, G. Wong, P. Bennet, J. Shaw, S. Caprio, and IDF consensus group, “The metabolic syndrome in children and adolescents-an IDF consensus report,” Pediatr. Diabetes, vol.8, no.5, pp. 299-306, 2007.
[7] K. Kouda, Y. Fujita, K. Ohara, T. Tachiki, J. Tamaki, A. Yura, J. S. Moon, E. Kajita, K. Uenishi, and M. Iki, “Associations between trunk-to-peripheral fat ratio and cardiometabolic risk factors in elderly Japanese men: baseline data from the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study,” Environ. Health Prev. Med., Vol.26, no.1, pp.35, Mar 2021.
[8] K. Kouda, H. Nakamura, K. Ohara, Y. Fujita, and M. Iki, “Increased ratio of trunk-to-appendicular fat and decreased adiponectin: A population-based study of school children in Hamamatsu, Japan,” J. Clin. Densitom., vol.20, no.1, pp. 66-72, Jan-Mar 2017.
[9] K. Kouda, H. Nakamura, Y. Fujita, K. Ohara, and M. Iki, “Increased ratio of trunk to appendicular fat and increased blood pressure: study of a general population of Hamamatsu children” Circ. J., vol.76, no.12, pp.2848-2854, 2012.
[10] K. Kouda, K. Ohara, Y. Fujita, H. Nakamura, and M. Iki, “Trunk-to-peripheral fat ratio predicts subsequent blood pressure levels in pubertal children with relatively low body fat-three-year follow-up study,” Circ. J., vol.80, no.8, pp.1838-1845, Jul. 2016.
[11] J. Pöss, F. Custodis, C. Werner, O. Weingärtner, M. Böhm, and U. Laufs, “Cardiovascular disease and dyslipidemia: beyond LDL,” Curr. Pharm. Des., vol.17, no.9, pp.861-70, 2011.
[12] M. Rossi, E. Fabris, D. Barbisan, L. Massa, and G. Sinagra, “Lipid-lowering drug therapy: Critical approach for implementation in clinical practice,” Am. J. Cardiovasc. Drugs., 2021 Sep 13. Epub ahead of print.
[13] WHO World Health Organization (WHO). The WHO Child Growth Standards. 2016 June. Access: http://www.who.int/childgrowth/en/
[14] G. C. Chen, R. Arthur, N. M. Iyengar, V. Kamensky, X. Xue, S. Wassertheil-Smoller, M. A. Allison, A. H. Shadyab, R. A. Wild, Y. Sun, H. R. Banack, J. C. Chai, J. Wactawski-Wende, J. E. Manson, M. L. Stefanick, A. J. Dannenberg, T. E. Rohan, and Q. Qi, “Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index,” Eur. Heart J., vol.40, no.34, pp.2849-2855, Sep. 2019.
[15] Y. Yan, J. Liu, X. Zhao, H. Cheng, G. Huang, J. Mi; China Child and Adolescent Cardiovascular Health (CCACH) Study Research Group, “Regional adipose compartments confer different cardiometabolic risk in children and adolescents: The China Child and Adolescent Cardiovascular Health Study,” Mayo Clin. Proc., vol.94, no.10, pp.1974-1982, Oct. 2019.
[16] N. Z. Mirhosseini, S. Shahar, M. Ghayour-Mobarhan, M. R. Parizadeh, N. A. Yusoff, and M. T. Shakeri, “Body fat distribution and its association with cardiovascular risk factors in adolescent Iranian girls,” Iran J. Pediatr., vol.22, no.2, pp.197-204, Jun 2012.
[17] W. Boorsma, M. B. Snijder, G. Nijpels, C. Guidone, A. M. Favuzzi, G. Mingrone, P. J. Kostense, R. J. Heine, and J. M. Dekker, “Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans,” Obesity (Silver Spring), vol.16, no.12, pp.2696-2701, Dec. 2008.
[18] Y. M. Kim, S. Kim, S. H. Kim, and Y. J. Won, “Clinical and body compositional factors associated with metabolic syndrome in obese Koreans: A cross-sectional study,” Metab. Syndr. Relat. Disord., vol.16, no.6, pp.290-298, Aug. 2018.
[19] H. N. Ginsberg, C. J. Packard, M. J. Chapman, J. Borén, C. A. Aguilar-Salinas, M. Averna, B. A. Ference, D. Gaudet, R. A. Hegele, S. Kersten, G. F. Lewis, A. H. Lichtenstein, P. Moulin, B. G. Nordestgaard, A. T. Remaley, B. Staels, E. S. G. Stroes, M. R. Taskinen, L. S. Tokgözoğlu, A. Tybjaerg-Hansen, J. K. Stock, and A. L. Catapano, “Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society,” Eur. Heart J., 2021 Sep 2:ehab551. Epub ahead of print.
[20] B. G. Nordestgaard, “Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology,” Circ. Res., vol.118, no.4, pp.547–563, Feb. 2016.
[21] A. Chait, H. N. Ginsberg, T. Vaisar, J. W. Heinecke, I. J. Goldberg, and K. E. Bornfeldt, “Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease,” Diabetes, vol.69, no.4, pp.508–516, Apr. 2020.
[22] K. Nakajima, and A. Tanaka, “Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis,” Clin. Chim. Acta, vol.478, pp.200–215, Mar. 2018.
[23] M. Farnier, M. Zeller, D. Masson, and Y. Cottin, “Triglycerides and risk of atherosclerotic cardiovascular disease: an update,” Arch. Cardiovasc. Dis., vol.114, no.2, pp.132–139, Feb. 2021.
[24] E. K. Duran, and A. D. Pradhan, “Triglyceride-rich lipoprotein remnants and cardiovascular disease,” Clin. Chem., vol.67, no.1, pp.183–196, Jan. 2021.
[25] J. Bore´n, M. J. Chapman, R. M. Krauss, C. J. Packard, J. F. Bentzon, C. J. Binder, M. J. Daemen, L. L. Demer, R. A. Hegele, S. J. Nicholls, B. G. Nordestgaard, G. F. Watts, E. Bruckert, S. Fazio, B. A. Ference, I. Graham, J. D. Horton, U. Landmesser, U. Laufs, L. Masana, G. Pasterkamp, F. J. Raal, K. K. Ray, H. Schunkert, M. R. Taskinen, B. van de Sluis, O. Wiklund, L. Tokgozoglu, A. L. Catapano, and H. N. Ginsberg, “Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel,” Eur. Heart J., vol.41, no. 24, pp.2313–2330, Jun. 2020.
[26] M. S. Brown, and J. L. Goldstein, “The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor,” Cell, vol.89, no.3, pp. 331–340, May 1997.
[27] B. A. Ference, H. N. Ginsberg, I. Graham, K. K. Ray, C. J. Packard, E. Bruckert, R. A. Hegele, R. M. Krauss, F. J. Raal, H. Schunkert, G. F. Watts, J. Bore´n, S. Fazio, J. D. Horton, L. Masana, S. J. Nicholls, B. G. Nordestgaard, B. van de Sluis, M. R. Taskinen, L. Tokgozoglu, U. Landmesser, U. Laufs, O. Wiklund, J. K. Stock, M. J. Chapman, and A. L. Catapano, “Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel,” Eur. Heart J., vol.38, no.32, pp.2459–2472, Aug. 2017.
[28] Y. Zhang, M. J. Pletcher, E. Vittinghoff, A. M. Clemons, D. R. Jacobs Jr, N. B. Allen, A. Alonso, B. K. Bellows, E. C. Oelsner, A. Zeki Al Hazzouri, D. S. Kazi, S. D. de Ferranti, and A. E. Moran, “Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events,” JAMA Cardiol., 2021 Sep 22. Epub ahead of print.